Oxicam: ASKC202 tablets approved for clinical trial

2022-05-05 0 By

February 15, Financial Union, Orsaikang announcement, subsidiary new drug ASKC202 tablets to obtain clinical trial approval notice.Disclaimer: This article is reproduced for the purpose of conveying more information.If the source is wrong or violated your legitimate rights and interests, please contact the author with proof of ownership, we will promptly correct, delete, thank you.Email address: newmedia@xxcb.cn